Sign in / Join Now
ETFs & Funds
AMITIZA treatment of opioid-induced constipation patients with chronic, non-cancer pain. FDA decision expected on 1/27/13. 250M
Add a reply...
Latest StockTalks »
people get SCMP breaking news and analysis by email alert.
Get email alerts on SCMP »
Sucampo Pharmaceuticals, Inc.
Get latest price
From other sites
Sucampo to Stop Developing Cobiprostone for Oral Mucositis
at Zacks.com (Jul 12, 2016)
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
at Zacks.com (Apr 1, 2016)
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Corcept Therapeutics, Sucampo Pharmaceuticals and Actelion
at Zacks.com (Mar 18, 2016)
Sucampo Beats Earnings & Revenues on Strong Amitiza Sales
at Zacks.com (Mar 9, 2016)
Sucampo (SCMP) Misses on Q3 Earnings, Focus on Amitiza
at Zacks.com (Nov 5, 2015)